- Home
- Equities - Stocks - Shares
- Company Press Releases
- Ultimovacs ASA: Share Capital Increase Related To Exercise of Options
Ultimovacs ASA: Share capital increase related to exercise of options
16 Nov 2022 11:56 CET
Issuer
Ultimovacs ASA
Oslo, 16 November 2022, the Board of Directors of Ultimovacs ASA (the "Company")
has resolved to increase the Company's share capital, related to the exercise of
options, by NOK 13,070 through the issuance of 130,700 new shares, each with a
par value of NOK 0.10. The resolution is based on an authorisation to increase
the share capital granted by the Company's general meeting on 21 April 2022.
Following the option exercise, 2,138,885 options are outstanding.
The new shares are issued to employees of the Company in connection with the
Company's employee incentive program. The new shares are issued at a
subscription price of NOK 31.25 per share for 127,592 shares and NOK 39.15 per
share for 3,108 shares.
Following registration of the share capital increase with the Norwegian Register
of Business Enterprises, the Company will have a share capital of NOK
3,439,646.10, divided into 34,396,461 shares, each with a par value of NOK 0.10.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Email: je@radforsk.no
Phone: +47 480 96 355
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632
More information:
Access the news on Oslo Bors NewsWeb site
Source
Ultimovacs ASA
Provider
Oslo Børs Newspoint
Company Name
ULTIMOVACS
ISIN
NO0010851603
Symbol
ULTI
Market
Oslo Børs